Hydrangeas are beautiful privacy plants that provide a bold statement in your garden, but many people believe a common myth ...

Costco offers a surprisingly broad selection of spring plants, bulbs, and shrubs, making it an affordable destination for ...

Hydrangeas come in a variety of shapes, sizes, and colors. Fine-tuning the options to your yard, your goals, and personal ...

Dark matter is a mysterious substance that glues galaxies together. This map from the James Webb Space Telescope could help scientists finally figure out what it is. Using data from the James Webb ...

When you make a purchase using links on our site, The Week may earn a commission. All reviews are written independently by our editorial team. Romance books have experienced a resurgence in popularity ...

Today marks the third Monday in January, known less than affectionately as Blue Monday due to the gloomy weather and post-Christmas blues. However it’s not all doom and gloom today, as Stacey Solomon ...

Ask any fashionable woman for her go-to pair of jeans when she wants to look smart, and I can guarantee she’ll point you in the direction of a rich, dark-blue was. Sleeker than lighter washes and ...

Dark matter, one of the Universe’s greatest mysteries, may have been born blazing hot instead of cold and sluggish as scientists long believed. New research shows that dark matter particles could have ...

Bo Bichette was a key player for the Toronto Blue Jays last season. However, they may not see him as a priority in free agency after signing Kazuma Okamoto. The Athletic's Mitch Bannon has noted that ...

Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 million. The acquisition will strengthen Amgen’s oncology pipeline by ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The California pharma has stitched together a deal worth up to $840 ...

Amgen has acquired U.K.-based biotechnology company Dark Blue Therapeutics in a transaction valued at up to $840 million. Amgen on Tuesday said the deal adds an investigational small molecule that ...